| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2 |
| P698 | PubMed publication ID | 10897069 |
| P2093 | author name string | Takahashi M | |
| Imagawa T | |||
| Yamanishi K | |||
| Gomi Y | |||
| P2860 | cites work | The complete DNA sequence of varicella-zoster virus | Q34162480 |
| Live vaccine used to prevent the spread of varicella in children in hospital | Q34202755 | ||
| Mutational analysis of varicella-zoster virus major immediate-early protein IE62. | Q34746607 | ||
| Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro | Q36465730 | ||
| Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis | Q41028258 | ||
| Enhancement of varicella-zoster virus infection in cell lines expressing ORF4- or ORF62-encoded proteins | Q41177944 | ||
| Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. | Q42603228 | ||
| A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V) | Q42613583 | ||
| Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein | Q42636451 | ||
| Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults | Q45835308 | ||
| Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI. | Q45836224 | ||
| Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes | Q45844946 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 497-503 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of Medical Virology | Q15716684 |
| P1476 | title | Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity | |
| P478 | volume | 61 |
| Q34252008 | 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview |
| Q34441066 | A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses |
| Q57215956 | Analysis of IE62 mutations found in Varicella-Zoster virus vaccine strains for transactivation activity |
| Q40668414 | Analysis of single nucleotide polymorphism among Varicella-Zoster Virus and identification of vaccine-specific sites |
| Q45522159 | Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model |
| Q39685482 | Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains. |
| Q38200971 | Clinical and molecular aspects of the live attenuated Oka varicella vaccine |
| Q40125719 | Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus |
| Q39685724 | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus |
| Q34434777 | Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus |
| Q34436222 | Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype |
| Q43251025 | Complete DNA sequences of two oka strain varicella-zoster virus genomes |
| Q45130208 | DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine |
| Q37420420 | Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. |
| Q35681513 | Effectiveness of live varicella vaccine |
| Q40041720 | Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. |
| Q37702470 | Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster |
| Q39911641 | Genome-wide reduction in transcriptomal profiles of varicella-zoster virus vaccine strains compared with parental Oka strain using long oligonucleotide microarrays |
| Q40567488 | Genomic analysis of varicella-zoster virus: primers for individual open reading frames. |
| Q42601933 | Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. |
| Q41066882 | Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR |
| Q36866120 | In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency. |
| Q38553727 | Insights into the function of tegument proteins from the varicella zoster virus |
| Q30531746 | Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo |
| Q37141176 | Molecular analysis of the Oka vaccine strain of varicella-zoster virus |
| Q41857926 | Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions |
| Q37932527 | Molecular studies of the Oka varicella vaccine |
| Q34977329 | Mutational Analysis of Open Reading Frames 62 and 71, Encoding the Varicella-Zoster Virus Immediate-Early Transactivating Protein, IE62, and Effects on Replication In Vitro and in Skin Xenografts in the SCID-hu Mouse In Vivo |
| Q35575931 | Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts |
| Q35942988 | Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster |
| Q43654246 | Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions |
| Q42292725 | Population diversity in batches of the varicella Oka vaccine |
| Q33719386 | Preventing varicella-zoster disease |
| Q35023792 | Promoter activation by the varicella-zoster virus major transactivator IE62 and the cellular transcription factor USF. |
| Q35758661 | Recombination of Globally Circulating Varicella-Zoster Virus |
| Q36284539 | Review of the Varilrix varicella vaccine |
| Q33724286 | Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo |
| Q40596107 | Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan. |
| Q42561314 | Stable and consistent genetic profile of Oka varicella vaccine virus is not linked with appearance of infrequent breakthrough cases postvaccination |
| Q45729323 | The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades |
| Q36987139 | Varicella-zoster virus infection of human neural cells in vivo. |
Search more.